Vir Biotechnology, Inc. - COMMON STOCK (VIR)

CUSIP: 92764N102

Q1 2025 13F Holders as of 31 Mar 2025

Holder snapshot 7 signals
Share change
+4,540,662
Put/Call ratio
102%
SEC-reported price per share
$6.48
Number of holders
230
Value change
+$27,869,791
Number of buys
122
Open additional details 1 more signal available
Number of sells
91
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
170,060,457

Security key

92764N102

Report period

Q1 2025

Institutions

230

Top holders

10

Ownership snapshot

Top reported holders of VIR - Vir Biotechnology, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
ARCH Venture Partners IX,...
Disclosed value leader
SB INVESTMENT ADVISERS (U...
Comparable rows
0/15
Latest evidence
24 Feb 2025
3/4/5 13F Highest disclosed value: $122,460,861 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

SB INVESTMENT ADVISERS (UK) LTD has the largest disclosed position value at $122.46M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens SB INVESTMENT ADVISERS (UK) LTD's linked filing trail.
Disclosed position value Top 5
ARCH Venture Partners IX, LLC $140.3K
SB INVESTMENT ADVISERS (UK) LTD $122.46M
BlackRock, Inc. $120.84M
VANGUARD GROUP INC $96.38M
STATE STREET CORP $37.25M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
ARCH Venture Partners IX, LLC
3/4/5
10%+ Owner
—
denominator unverified
$140,347
91,730 shares
— 02 Sep 2022
SB INVESTMENT ADVISERS (UK) LTD
13F
Company
13F
—
denominator unverified
$122,460,861
16,684,041 shares
— 31 Dec 2024
BlackRock, Inc.
13F
Company
13F
—
denominator unverified
$120,836,342
16,462,717 shares
— 31 Dec 2024
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$96,378,861
13,130,635 shares
— 31 Dec 2024
STATE STREET CORP
13F
Company
13F
—
denominator unverified
$37,248,526
5,074,731 shares
— 31 Dec 2024
ORBIMED ADVISORS LLC
13F
Company
13F
—
denominator unverified
$23,624,649
3,218,617 shares
— 31 Dec 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
230
Shares
93,307,654
Rows available
230
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2025 vs Q1 2025 Across Filers

Q1 2025 holders
230
Q1 2025 holders
230
Holder diff
0
Investor Q1 2025 Shares Q1 2025 Shares Share Diff Share Chg % Q1 2025 value Q1 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .